Section Items Management
Search, edit, and delete section items
| ID | Section | Name | Created At | Actions |
|---|---|---|---|---|
| 72 | Treatment | ALT normalization | 12 Jan 2026 | |
| 71 | Treatment | Change in weight after follow-up | 12 Jan 2026 | |
| 70 | Treatment | Follow-up duration (months) | 12 Jan 2026 | |
| 69 | Treatment | On Pioglitazone | 12 Jan 2026 | |
| 68 | Treatment | On Vitamin E | 12 Jan 2026 | |
| 67 | Treatment | On statins | 12 Jan 2026 | |
| 66 | Treatment | On antidiabetic medication | 12 Jan 2026 | |
| 65 | Treatment | On lifestyle modification program | 12 Jan 2026 | |
| 64 | Lifestyle | Smoking history | 12 Jan 2026 | |
| 63 | Lifestyle | Diet pattern | 12 Jan 2026 | |
| 62 | Lifestyle | Physical activity | 12 Jan 2026 | |
| 60 | Complication | Cardiovascular disease history | 12 Jan 2026 | |
| 59 | Complication | HCC | 12 Jan 2026 | |
| 58 | Complication | Decompensation features | 12 Jan 2026 | |
| 57 | Complication | Liver cirrhosis | 12 Jan 2026 | |
| 56 | Imaging | Portal hypertension signs | 12 Jan 2026 | |
| 55 | Imaging | Splenomegaly | 12 Jan 2026 | |
| 54 | Imaging | Hepatomegaly | 12 Jan 2026 | |
| 53 | Imaging | Ultrasound findings | 12 Jan 2026 | |
| 52 | Fibrosis | APRI score | 12 Jan 2026 | |
| 51 | Fibrosis | NFS (NAFLD Fibrosis Score) | 12 Jan 2026 | |
| 50 | Fibrosis | FIB-4 score (auto-calculated) | 12 Jan 2026 | |
| 49 | Fibrosis | Fibro Scan / VCTE | 12 Jan 2026 | |
| 46 | Lab | Viral hepatitis markers | 07 Jan 2026 | |
| 45 | Lab | TSH | 07 Jan 2026 | |
| 44 | Lab | Lipid profile (TC, TG, HDL, LDL) | 07 Jan 2026 | |
| 43 | Lab | HbA1c | 07 Jan 2026 | |
| 42 | Lab | Fasting insulin | 07 Jan 2026 | |
| 41 | Lab | Fasting glucose | 07 Jan 2026 | |
| 40 | Lab | Platelet count | 07 Jan 2026 | |
| 39 | Lab | GGT (U/L) | 07 Jan 2026 | |
| 38 | Lab | ALP (U/L) | 07 Jan 2026 | |
| 37 | Lab | AST (U/L) | 07 Jan 2026 | |
| 36 | Lab | ALT (U/L) | 07 Jan 2026 | |
| 35 | Metabolic | HOMA-IR (if available) | 07 Jan 2026 | |
| 34 | Metabolic | BP ≥130/85 or on medication | 07 Jan 2026 | |
| 33 | Metabolic | HDL low (M <40, F <50) | 07 Jan 2026 | |
| 32 | Metabolic | Triglycerides ≥ 150 mg/dl | 07 Jan 2026 | |
| 31 | Metabolic | Prediabetes | 07 Jan 2026 | |
| 30 | Metabolic | DM criteria met? | 07 Jan 2026 | |
| 29 | Metabolic | Central obesity (waist ≥ 90 cm men, ≥ 80 cm women) | 07 Jan 2026 | |
| 28 | Alcohol | Meets safe limit? | 07 Jan 2026 | |
| 27 | Alcohol | Average grams of alcohol per week | 07 Jan 2026 | |
| 26 | Alcohol | Alcohol consumption | 07 Jan 2026 | |
| 25 | Clinical | Family history of liver disease | 07 Jan 2026 | |
| 24 | Clinical | Obstructive sleep apnea | 07 Jan 2026 | |
| 23 | Clinical | Hypothyroidism | 07 Jan 2026 | |
| 22 | Clinical | Dyslipidemia | 07 Jan 2026 | |
| 21 | Clinical | History of Hypertension | 07 Jan 2026 | |
| 19 | Clinical | History of Diabetes Mellitus | 07 Jan 2026 | |
| 18 | Clinical | Symptoms at presentation : | 07 Jan 2026 | |
| 16 | Clinical | Duration of symptoms : | 07 Jan 2026 |